We follow a simple strategy that is based on four principles:
We invest almost exclusively in the medical technology space, and consider investments across all med-tech sub-sectors, such as cardiovascular, imaging, orthopaedics, molecular diagnostics, ophthalmology etc.
We primarily invest and have experience investing in main EU countries (including Switzerland) but also selectively consider investments in non-EU countries such as US and Israel.
We aim to diversify our portfolio over stage of company and therefore consider a broad array of companies ranging from pre-prototype to multi-million revenue generating. Our investment amounts depend on the stage of the company and can vary between €1M to €10M, although typically average about €3-4M.
We are active investors that aim to bringing expertise, a strong contact network as well as specific and valuable knowledge to our investee companies.